中国药房2016，Vol.27Issue(15)：2032-2034,3.DOI:10.6039/j.issn.1001-0408.2016.15.05
我院服用华法林患者抗凝治疗质量评价
Quality Evaluation of Anticoagulant Therapy in Patients Who Taking Warfarin in Our Hospital
摘要
Abstract
OBJECTIVE:To evaluate the quality of anticoagulant therapy in patients who took warfarin and provide data sup-porting for strengthening the management of these patients. METHODS:A retrospective analysis of related clinical data of 214 pa-tients who meet the inclusion criteria was performed. RESULTS:The average time for patients took warfarin was (321.64 ± 189.50)d,average times for tested INR was(12.01±7.03)times in clinic;when anticoagulant therapy,INR<2.0 accounted for 51.96%,2.0≤INR≤3.0 accounted for 39.13%,and INR>3.0 accounted for 8.91%;patients with target INR≤2.0 accounted for 45.33%,target INR=2.5 accounted for 38.32%,and target INR≥3.0 accounted for 0.93%;the average TTR was (50.80 ± 22.32)%;and there was no statistical significance in the TTR of different ages and diseases(P>0.05). CONCLUSIONS:The anti-coagulant therapy in some patients who took warfarin shows poor quality,it needs strengthening the quality management to make it safe and effective.关键词
华法林/抗凝治疗/目标范围内时间百分比/国际标准化比值/质量评价Key words
Warfarin/Anticoagulant therapy/Time in therapeutic range/International normalized ratio/Quality evaluation分类
医药卫生引用本文复制引用
李玲玲,李莹,都丽萍,李雯,梅丹..我院服用华法林患者抗凝治疗质量评价[J].中国药房,2016,27(15):2032-2034,3.基金项目
国家临床重点专科建设项目 （）
